Fisher & Paykel Healthcare Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Lewis Gradon
Chief executive officer
NZ$3.7m
Total compensation
| CEO salary percentage | 46.5% |
| CEO tenure | 8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.9yrs |
| Board average tenure | 6.1yrs |
Recent management updates
Recent updates
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
May 01Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching
Mar 28Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 16Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?
Mar 04How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?
Feb 20Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 05Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?
Jan 25Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?
Jan 14Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like
Jan 03Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?
Dec 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$4m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
Compensation vs Market: Lewis's total compensation ($USD2.18M) is below average for companies of similar size in the NZ market ($USD4.02M).
Compensation vs Earnings: Lewis's compensation has been consistent with company performance over the past year.
CEO
Lewis Gradon (62 yo)
8yrs
Tenure
NZ$3,672,241
Compensation
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8yrs | NZ$3.67m | 0.099% NZ$ 16.1m | |
| Chief Financial Officer | 5.1yrs | no data | 0.000010% NZ$ 1.6k | |
| COO & GM of Respiratory Humidification | no data | no data | no data | |
| Vice President of Products & Technology | 8yrs | no data | 0.018% NZ$ 2.9m | |
| Head of Capital Markets & Investor Relations | no data | no data | no data | |
| Company Secretary & General Counsel | no data | no data | no data | |
| Senior Communications & Investor Relations Manager | no data | no data | no data | |
| VP of Sales & Marketing and President of North America & Europe | no data | no data | no data | |
| Vice President of Human Resources | 3.5yrs | no data | no data | |
| Vice President of Supply Chain | 2.3yrs | no data | no data | |
| Vice President of Corporate | no data | no data | no data | |
| General Manager of Airvo Optiflow | no data | no data | no data |
2.9yrs
Average Tenure
Experienced Management: FPH's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8yrs | NZ$3.67m | 0.099% NZ$ 16.1m | |
| Non-Executive Director | 22.4yrs | NZ$160.90k | 0.15% NZ$ 25.1m | |
| Independent Non-Executive Director | 5.4yrs | NZ$212.81k | 0.0013% NZ$ 205.1k | |
| Independent Chairman | 8.5yrs | NZ$284.97k | 0.0039% NZ$ 628.2k | |
| Independent Non-Executive Director | 2.5yrs | NZ$181.84k | 0.0023% NZ$ 374.3k | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Non-Executive Independent Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 6.8yrs | NZ$165.21k | 0.00065% NZ$ 105.8k | |
| Independent Non-Executive Director | 1.8yrs | NZ$129.19k | 0.00021% NZ$ 34.2k | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Member of EcoDesign Advisory Board | no data | no data | no data |
6.1yrs
Average Tenure
62yo
Average Age
Experienced Board: FPH's board of directors are considered experienced (6.1 years average tenure).